Related Experiment Video
Updated: Jan 2, 2026

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
Published on: July 12, 2018
A comparison of diverticulitis in Crohn's disease versus ulcerative colitis
Alana Persaud1, Ahmed Ahmed1, Gaurav Kakked2
1Division of Medicine Rutgers New Jersey Medical School Newark New Jersey USA.
Insights
Hospitalization for diverticulitis in patients with ulcerative colitis (UC) leads to worse outcomes than in those with Crohn's disease (CD). This suggests differences in disease burden and management strategies for inflammatory bowel disease patients experiencing diverticulitis.
Area of Science:
- Gastroenterology
- Colorectal Surgery
- Health Services Research
Background:
- Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), significantly increases patient morbidity, particularly during inpatient hospitalizations.
- Diverticulitis, a common condition, can exacerbate the health burden in IBD patients.
Purpose of the Study:
- To compare the hospitalization burden of diverticulitis between patients with a history of Crohn's disease (CD) and ulcerative colitis (UC).
- To identify differences in mortality, admission costs, length of stay (LOS), and colectomy rates.
Main Methods:
- Utilized the national inpatient sample from 2014 to identify patients hospitalized for acute diverticulitis with pre-existing UC or CD.
- Employed International Classification of Diseases, Ninth Edition codes for case identification.
- Analyzed primary outcomes including mortality, cost of admission, LOS, and colectomy.
Main Results:
- Patients with CD experienced decreased hospitalization costs (aOR -14,537; P=0.026) and shorter LOS (aOR -1.31; P=0.02) compared to UC patients.
- No significant differences in mortality, LOS, or cost were observed when comparing CD patients to those without IBD.
- Colectomy rates may contribute to the observed differences, though etiology is likely multifactorial.
Conclusions:
- Ulcerative colitis patients exhibit poorer hospitalization outcomes for diverticulitis compared to Crohn's disease patients.
- The disparity in outcomes may be linked to variations in colectomy rates and other uncharacterized factors.
- Further research is warranted to fully elucidate the associations between IBD subtypes and diverticulitis hospitalization burden.
Background And Aim:
Inflammatory bowel disease (IBD) and diverticulitis both increase morbidity, especially when associated with in-patient hospitalization. This study aimed to evaluate whether hospitalization burden differs for diverticulitis in patients with a history of Crohn's disease (CD) compared to ulcerative colitis (UC).
Method:
All patients hospitalized for acute diverticulitis with pre-existing UC or CD in 2014 were selected using the national in-patient sample. Cases were identified using the International Classification of Diseases, Ninth Edition codes. Primary outcomes were mortality, cost of admission, length of stay (LOS), and colectomy.
Results:
A total of 1815 patients were admitted with diverticulitis, and those with CD had a hospitalization associated with decreased cost (aOR -14 537, 95% CI -27 316 to -1758; P = 0.026) and LOS (aOR -1.31, 95% CI -2.41 to -0.208; P = 0.02) compared to UC. A second analysis comparing diverticulitis hospitalization between those with CD and those with the absence of IBD showed no significant difference in mortality (aOR 2.47, 95% CI 0.59 to 10.36; P = 0.22), LOS (aOR 0.03, 95% CI -0.47 to 0.54; P = 0.92), or cost of admission (aOR -2196, 95% CI -6933 to 2539; P = 0.36) between the cohorts.
Conclusion:
Patients with UC have worsened hospitalization outcomes when being treated for diverticulitis compared to CD. While the findings may be a result of a difference in colectomy rates, the etiology may also be multifactorial. These conclusions have not been previously described, and further investigations would better characterize these associations.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD

